[{"address1": "1111 Dr. Frederik-Philips Boulevard", "address2": "Suite 420", "city": "Montreal", "state": "QC", "zip": "H4M 2X6", "country": "Canada", "phone": "514 336 0444", "website": "https://www.milestonepharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph G. Oliveto M.B.A.", "age": 57, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 882261, "exercisedValue": 0, "unexercisedValue": 255224}, {"maxAge": 1, "name": "Mr. Amit  Hasija", "age": 52, "title": "CFO & Executive VP of Corporate Development", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 601517, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David B. Bharucha FACC, M.D., Ph.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 636174, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Douville M.B.A., Ph.D.", "age": 63, "title": "Founder, Strategic Advisor & Member of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Nelson", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Sandoval", "age": 46, "title": "General Counsel & Chief Compliance Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roshan  Girglani", "title": "Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Moore", "title": "Vice President of Sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.", "age": 69, "title": "Chief Medical Advisor & Member of the Scientific Advisory Board", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Guy  Rousseau", "title": "SVP of Regulatory Affairs and Quality Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.68, "open": 1.67, "dayLow": 1.6463, "dayHigh": 1.74, "regularMarketPreviousClose": 1.68, "regularMarketOpen": 1.67, "regularMarketDayLow": 1.6463, "regularMarketDayHigh": 1.74, "payoutRatio": 0.0, "beta": 0.463, "forwardPE": -2.8491464, "volume": 1500744, "regularMarketVolume": 1500744, "averageVolume": 5307208, "averageVolume10days": 2068650, "averageDailyVolume10Day": 2068650, "bid": 1.68, "ask": 1.76, "bidSize": 15, "askSize": 15, "marketCap": 144787888, "fiftyTwoWeekLow": 0.625, "fiftyTwoWeekHigh": 3.06, "allTimeHigh": 27.95, "allTimeLow": 0.625, "fiftyDayAverage": 2.0947, "twoHundredDayAverage": 1.865475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 147312864, "profitMargins": 0.0, "floatShares": 84007521, "sharesOutstanding": 85169344, "sharesShort": 9597134, "sharesShortPriorMonth": 8250257, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.11270001, "heldPercentInsiders": 0.03313, "heldPercentInstitutions": 0.41744998, "shortRatio": 3.16, "shortPercentOfFloat": 0.11270001, "impliedSharesOutstanding": 85169345, "bookValue": 0.202, "priceToBook": 8.415841, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -58012000, "trailingEps": -0.79, "forwardEps": -0.59667, "enterpriseToEbitda": -2.579, "52WeekChange": -0.23076922, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 1.7, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 6.6, "targetMedianPrice": 8.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 82585000, "totalCashPerShare": 0.813, "ebitda": -57125000, "totalDebt": 57208000, "quickRatio": 7.985, "currentRatio": 8.235, "debtToEquity": 279.05, "returnOnAssets": -0.41969, "returnOnEquity": -2.6065202, "freeCashflow": -25872876, "operatingCashflow": -43109000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1771634734, "regularMarketTime": 1771621202, "exchange": "NMS", "messageBoardId": "finmb_36171059", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.19048, "regularMarketPrice": 1.7, "shortName": "Milestone Pharmaceuticals Inc.", "longName": "Milestone Pharmaceuticals Inc.", "earningsTimestampStart": 1773322200, "earningsTimestampEnd": 1773322200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.79, "epsForward": -0.59667, "epsCurrentYear": -0.71333, "priceEpsCurrentYear": -2.383189, "fiftyDayAverageChange": -0.39470005, "fiftyDayAverageChangePercent": -0.18842795, "twoHundredDayAverageChange": -0.16547501, "twoHundredDayAverageChangePercent": -0.08870395, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1557408600000, "postMarketChangePercent": -1.7647111, "postMarketPrice": 1.67, "postMarketChange": -0.03000009, "regularMarketChange": 0.0200001, "regularMarketDayRange": "1.6463 - 1.74", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5307208, "fiftyTwoWeekLowChange": 1.075, "fiftyTwoWeekLowChangePercent": 1.72, "fiftyTwoWeekRange": "0.625 - 3.06", "fiftyTwoWeekHighChange": -1.3599999, "fiftyTwoWeekHighChangePercent": -0.44444442, "fiftyTwoWeekChangePercent": -23.076921, "displayName": "Milestone Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]